Sanofi and Translate Bio commence Phase I influenza vaccine trial
Sanofi Pasteur and Translate Bio have commenced a Phase I clinical trial in the US to assess an investigational messenger ribonucleic acid (mRNA)-based vaccine candidate…
Patent Analytics
Trends in IP Protection— Clinical Trials Arena (Last 20 Years)
Heavy IP Protected Regions — Clinical Trials Arena (Last 20 Years)
Top Players Protecting their IP — Clinical Trials Arena (Last 20 Years)
Top Themes Protected by IP - Clinical Trials Arena (Last 20 Years)
All markets data shared in the dashboard is copyright of GlobalData PLC and is subject to the GlobalData Terms & Conditions. Content in the dashboard should not be viewed as a recommendation and should not be relied upon to make investment decisions. We make every effort to ensure our content is accurate and to correct mistakes as soon as possible. If you spot an error please email editorialenquiries@globaldata.com. Further information about our editorial standards and complaints procedure is available here. GlobalData is not responsible for the use of any content outside the scope of the GlobalData Terms & Conditions.
Latest News
View More
Covaxin Phase III data shows jab to be 77.8% effective ahead of WHO meeting
Long-awaited data of Bharat Biotech’s Covid-19 vaccine Covaxin has demonstrated a 77.8% efficacy in Phase III trials. The Subject Expert Committee (SEC) met on Tuesday…
Histogen-Amerimmune’s emricasan yields positive results in Covid-19 trial
Histogen and its partner Amerimmune have reported top-line data from the Phase I clinical trial where emricasan was found to…
UK announces funding support to bolster clinical research
The UK Government has announced about £64m in funding to support patient-centred clinical research delivery across the country. This investment…
Oxford University adds ivermectin to PRINCIPLE trial for Covid-19
The University of Oxford in the UK has added ivermectin to the Platform Randomised Trial of Treatments in the Community…
Roche Alzheimer’s drug yields mixed results in WUSTL study
Washington University School of Medicine in St Louis (WUSTL) in the US has reported that Roche’s investigational drug, gantenerumab, lowered…
Company A-Z
View More
GlobalData
GlobalData exists to help businesses decode the future to profit from faster, more informed decisions.
